OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Florey Institute of Neuroscience and Mental Health

5 Projects | 3 Researchers | $1,109,518 Invested

2023

Florey Institute of Neuroscience and Mental Health

Colin Masters, MD

Diagnostics Accelerator Speech & Language Consortium: Harmonized Repository for the Exploration of Speech and Language Biomarkers for Neurodegenerative Disease

  • Funding Amount: $650,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Status: Active

2017

Florey Institute of Neuroscience and Mental Health

Blaine Roberts, PhD

Plasma Abeta protein complexes for the early detection of brain amyloid accumulation.

  • Funding Amount: $149,518
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2013

Florey Institute of Neuroscience and Mental Health

Blaine Roberts, PhD

Validation of an effective blood test for Alzheimer's disease.

  • Funding Amount: $140,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2007

Florey Institute of Neuroscience and Mental Health

Siew Chai, PhD

IRAP - novel target for the development of memory-enhancing agents

  • Funding Amount: $88,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

Florey Institute of Neuroscience and Mental Health

Siew Chai, PhD

IRAP - novel target for the development of memory-enhancing agents

  • Funding Amount: $82,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed